table of content
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.4.1 North America Market States and Outlook (2023-2028)
1.4.2 East Asia Market States and Outlook (2023-2028)
1.4.3 Europe Market States and Outlook (2023-2028)
1.4.4 South Asia Market States and Outlook (2023-2028)
1.4.5 Southeast Asia Market States and Outlook (2023-2028)
1.4.6 Middle East Market States and Outlook (2023-2028)
1.4.7 Africa Market States and Outlook (2023-2028)
1.4.8 Oceania Market States and Outlook (2023-2028)
1.4.9 South America Market States and Outlook (2023-2028)
1.5 Global Psoriasis Drugs Market Size Analysis from 2023 to 2028
1.5.1 Global Psoriasis Drugs Market Size Analysis from 2023 to 2028 by Consumption Volume
1.5.2 Global Psoriasis Drugs Market Size Analysis from 2023 to 2028 by Value
1.5.3 Global Psoriasis Drugs Price Trends Analysis from 2023 to 2028
1.6 COVID-19 Outbreak: Psoriasis Drugs Industry Impact
Chapter 2 Global Psoriasis Drugs Competition by Types, Applications, and Top Regions and Countries
2.1 Global Psoriasis Drugs (Volume and Value) by Type
2.1.1 Global Psoriasis Drugs Consumption and Market Share by Type (2017-2022)
2.1.2 Global Psoriasis Drugs Revenue and Market Share by Type (2017-2022)
2.2 Global Psoriasis Drugs (Volume and Value) by Application
2.2.1 Global Psoriasis Drugs Consumption and Market Share by Application (2017-2022)
2.2.2 Global Psoriasis Drugs Revenue and Market Share by Application (2017-2022)
2.3 Global Psoriasis Drugs (Volume and Value) by Regions
2.3.1 Global Psoriasis Drugs Consumption and Market Share by Regions (2017-2022)
2.3.2 Global Psoriasis Drugs Revenue and Market Share by Regions (2017-2022)
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.1.1 2017-2022 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis
3.1.2 2017-2022 Major Manufacturers Performance and Market Share
3.2 Regional Production Market Analysis
3.2.1 2017-2022 Regional Market Performance and Market Share
3.2.2 North America Market
3.2.3 East Asia Market
3.2.4 Europe Market
3.2.5 South Asia Market
3.2.6 Southeast Asia Market
3.2.7 Middle East Market
3.2.8 Africa Market
3.2.9 Oceania Market
3.2.10 South America Market
3.2.11 Rest of the World Market
Chapter 4 Global Psoriasis Drugs Sales, Consumption, Export, Import by Regions (2017-2022)
4.1 Global Psoriasis Drugs Consumption by Regions (2017-2022)
4.2 North America Psoriasis Drugs Sales, Consumption, Export, Import (2017-2022)
4.3 East Asia Psoriasis Drugs Sales, Consumption, Export, Import (2017-2022)
4.4 Europe Psoriasis Drugs Sales, Consumption, Export, Import (2017-2022)
4.5 South Asia Psoriasis Drugs Sales, Consumption, Export, Import (2017-2022)
4.6 Southeast Asia Psoriasis Drugs Sales, Consumption, Export, Import (2017-2022)
4.7 Middle East Psoriasis Drugs Sales, Consumption, Export, Import (2017-2022)
4.8 Africa Psoriasis Drugs Sales, Consumption, Export, Import (2017-2022)
4.9 Oceania Psoriasis Drugs Sales, Consumption, Export, Import (2017-2022)
4.10 South America Psoriasis Drugs Sales, Consumption, Export, Import (2017-2022)
Chapter 5 North America Psoriasis Drugs Market Analysis
5.1 North America Psoriasis Drugs Consumption and Value Analysis
5.1.1 North America Psoriasis Drugs Market Under COVID-19
5.2 North America Psoriasis Drugs Consumption Volume by Types
5.3 North America Psoriasis Drugs Consumption Structure by Application
5.4 North America Psoriasis Drugs Consumption by Top Countries
5.4.1 United States Psoriasis Drugs Consumption Volume from 2017 to 2022
5.4.2 Canada Psoriasis Drugs Consumption Volume from 2017 to 2022
5.4.3 Mexico Psoriasis Drugs Consumption Volume from 2017 to 2022
Chapter 6 East Asia Psoriasis Drugs Market Analysis
6.1 East Asia Psoriasis Drugs Consumption and Value Analysis
6.1.1 East Asia Psoriasis Drugs Market Under COVID-19
6.2 East Asia Psoriasis Drugs Consumption Volume by Types
6.3 East Asia Psoriasis Drugs Consumption Structure by Application
6.4 East Asia Psoriasis Drugs Consumption by Top Countries
6.4.1 China Psoriasis Drugs Consumption Volume from 2017 to 2022
6.4.2 Japan Psoriasis Drugs Consumption Volume from 2017 to 2022
6.4.3 South Korea Psoriasis Drugs Consumption Volume from 2017 to 2022
Chapter 7 Europe Psoriasis Drugs Market Analysis
7.1 Europe Psoriasis Drugs Consumption and Value Analysis
7.1.1 Europe Psoriasis Drugs Market Under COVID-19
7.2 Europe Psoriasis Drugs Consumption Volume by Types
7.3 Europe Psoriasis Drugs Consumption Structure by Application
7.4 Europe Psoriasis Drugs Consumption by Top Countries
7.4.1 Germany Psoriasis Drugs Consumption Volume from 2017 to 2022
7.4.2 UK Psoriasis Drugs Consumption Volume from 2017 to 2022
7.4.3 France Psoriasis Drugs Consumption Volume from 2017 to 2022
7.4.4 Italy Psoriasis Drugs Consumption Volume from 2017 to 2022
7.4.5 Russia Psoriasis Drugs Consumption Volume from 2017 to 2022
7.4.6 Spain Psoriasis Drugs Consumption Volume from 2017 to 2022
7.4.7 Netherlands Psoriasis Drugs Consumption Volume from 2017 to 2022
7.4.8 Switzerland Psoriasis Drugs Consumption Volume from 2017 to 2022
7.4.9 Poland Psoriasis Drugs Consumption Volume from 2017 to 2022
Chapter 8 South Asia Psoriasis Drugs Market Analysis
8.1 South Asia Psoriasis Drugs Consumption and Value Analysis
8.1.1 South Asia Psoriasis Drugs Market Under COVID-19
8.2 South Asia Psoriasis Drugs Consumption Volume by Types
8.3 South Asia Psoriasis Drugs Consumption Structure by Application
8.4 South Asia Psoriasis Drugs Consumption by Top Countries
8.4.1 India Psoriasis Drugs Consumption Volume from 2017 to 2022
8.4.2 Pakistan Psoriasis Drugs Consumption Volume from 2017 to 2022
8.4.3 Bangladesh Psoriasis Drugs Consumption Volume from 2017 to 2022
Chapter 9 Southeast Asia Psoriasis Drugs Market Analysis
9.1 Southeast Asia Psoriasis Drugs Consumption and Value Analysis
9.1.1 Southeast Asia Psoriasis Drugs Market Under COVID-19
9.2 Southeast Asia Psoriasis Drugs Consumption Volume by Types
9.3 Southeast Asia Psoriasis Drugs Consumption Structure by Application
9.4 Southeast Asia Psoriasis Drugs Consumption by Top Countries
9.4.1 Indonesia Psoriasis Drugs Consumption Volume from 2017 to 2022
9.4.2 Thailand Psoriasis Drugs Consumption Volume from 2017 to 2022
9.4.3 Singapore Psoriasis Drugs Consumption Volume from 2017 to 2022
9.4.4 Malaysia Psoriasis Drugs Consumption Volume from 2017 to 2022
9.4.5 Philippines Psoriasis Drugs Consumption Volume from 2017 to 2022
9.4.6 Vietnam Psoriasis Drugs Consumption Volume from 2017 to 2022
9.4.7 Myanmar Psoriasis Drugs Consumption Volume from 2017 to 2022
Chapter 10 Middle East Psoriasis Drugs Market Analysis
10.1 Middle East Psoriasis Drugs Consumption and Value Analysis
10.1.1 Middle East Psoriasis Drugs Market Under COVID-19
10.2 Middle East Psoriasis Drugs Consumption Volume by Types
10.3 Middle East Psoriasis Drugs Consumption Structure by Application
10.4 Middle East Psoriasis Drugs Consumption by Top Countries
10.4.1 Turkey Psoriasis Drugs Consumption Volume from 2017 to 2022
10.4.2 Saudi Arabia Psoriasis Drugs Consumption Volume from 2017 to 2022
10.4.3 Iran Psoriasis Drugs Consumption Volume from 2017 to 2022
10.4.4 United Arab Emirates Psoriasis Drugs Consumption Volume from 2017 to 2022
10.4.5 Israel Psoriasis Drugs Consumption Volume from 2017 to 2022
10.4.6 Iraq Psoriasis Drugs Consumption Volume from 2017 to 2022
10.4.7 Qatar Psoriasis Drugs Consumption Volume from 2017 to 2022
10.4.8 Kuwait Psoriasis Drugs Consumption Volume from 2017 to 2022
10.4.9 Oman Psoriasis Drugs Consumption Volume from 2017 to 2022
Chapter 11 Africa Psoriasis Drugs Market Analysis
11.1 Africa Psoriasis Drugs Consumption and Value Analysis
11.1.1 Africa Psoriasis Drugs Market Under COVID-19
11.2 Africa Psoriasis Drugs Consumption Volume by Types
11.3 Africa Psoriasis Drugs Consumption Structure by Application
11.4 Africa Psoriasis Drugs Consumption by Top Countries
11.4.1 Nigeria Psoriasis Drugs Consumption Volume from 2017 to 2022
11.4.2 South Africa Psoriasis Drugs Consumption Volume from 2017 to 2022
11.4.3 Egypt Psoriasis Drugs Consumption Volume from 2017 to 2022
11.4.4 Algeria Psoriasis Drugs Consumption Volume from 2017 to 2022
11.4.5 Morocco Psoriasis Drugs Consumption Volume from 2017 to 2022
Chapter 12 Oceania Psoriasis Drugs Market Analysis
12.1 Oceania Psoriasis Drugs Consumption and Value Analysis
12.2 Oceania Psoriasis Drugs Consumption Volume by Types
12.3 Oceania Psoriasis Drugs Consumption Structure by Application
12.4 Oceania Psoriasis Drugs Consumption by Top Countries
12.4.1 Australia Psoriasis Drugs Consumption Volume from 2017 to 2022
12.4.2 New Zealand Psoriasis Drugs Consumption Volume from 2017 to 2022
Chapter 13 South America Psoriasis Drugs Market Analysis
13.1 South America Psoriasis Drugs Consumption and Value Analysis
13.1.1 South America Psoriasis Drugs Market Under COVID-19
13.2 South America Psoriasis Drugs Consumption Volume by Types
13.3 South America Psoriasis Drugs Consumption Structure by Application
13.4 South America Psoriasis Drugs Consumption Volume by Major Countries
13.4.1 Brazil Psoriasis Drugs Consumption Volume from 2017 to 2022
13.4.2 Argentina Psoriasis Drugs Consumption Volume from 2017 to 2022
13.4.3 Columbia Psoriasis Drugs Consumption Volume from 2017 to 2022
13.4.4 Chile Psoriasis Drugs Consumption Volume from 2017 to 2022
13.4.5 Venezuela Psoriasis Drugs Consumption Volume from 2017 to 2022
13.4.6 Peru Psoriasis Drugs Consumption Volume from 2017 to 2022
13.4.7 Puerto Rico Psoriasis Drugs Consumption Volume from 2017 to 2022
13.4.8 Ecuador Psoriasis Drugs Consumption Volume from 2017 to 2022
Chapter 14 Company Profiles and Key Figures in Psoriasis Drugs Business
14.1 AbbVie
14.1.1 AbbVie Company Profile
14.1.2 AbbVie Psoriasis Drugs Product Specification
14.1.3 AbbVie Psoriasis Drugs Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.2 Amgen
14.2.1 Amgen Company Profile
14.2.2 Amgen Psoriasis Drugs Product Specification
14.2.3 Amgen Psoriasis Drugs Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.3 Johnson & Johnson
14.3.1 Johnson & Johnson Company Profile
14.3.2 Johnson & Johnson Psoriasis Drugs Product Specification
14.3.3 Johnson & Johnson Psoriasis Drugs Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.4 Novartis
14.4.1 Novartis Company Profile
14.4.2 Novartis Psoriasis Drugs Product Specification
14.4.3 Novartis Psoriasis Drugs Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.5 Eli Lilly & Company
14.5.1 Eli Lilly & Company Company Profile
14.5.2 Eli Lilly & Company Psoriasis Drugs Product Specification
14.5.3 Eli Lilly & Company Psoriasis Drugs Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.6 AstraZeneca
14.6.1 AstraZeneca Company Profile
14.6.2 AstraZeneca Psoriasis Drugs Product Specification
14.6.3 AstraZeneca Psoriasis Drugs Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.7 Celgene Corporation
14.7.1 Celgene Corporation Company Profile
14.7.2 Celgene Corporation Psoriasis Drugs Product Specification
14.7.3 Celgene Corporation Psoriasis Drugs Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.8 UCB
14.8.1 UCB Company Profile
14.8.2 UCB Psoriasis Drugs Product Specification
14.8.3 UCB Psoriasis Drugs Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.9 Merck
14.9.1 Merck Company Profile
14.9.2 Merck Psoriasis Drugs Product Specification
14.9.3 Merck Psoriasis Drugs Production Capacity, Revenue, Price and Gross Margin (2017-2022)
Chapter 15 Global Psoriasis Drugs Market Forecast (2023-2028)
15.1 Global Psoriasis Drugs Consumption Volume, Revenue and Price Forecast (2023-2028)
15.1.1 Global Psoriasis Drugs Consumption Volume and Growth Rate Forecast (2023-2028)
15.1.2 Global Psoriasis Drugs Value and Growth Rate Forecast (2023-2028)
15.2 Global Psoriasis Drugs Consumption Volume, Value and Growth Rate Forecast by Region (2023-2028)
15.2.1 Global Psoriasis Drugs Consumption Volume and Growth Rate Forecast by Regions (2023-2028)
15.2.2 Global Psoriasis Drugs Value and Growth Rate Forecast by Regions (2023-2028)
15.2.3 North America Psoriasis Drugs Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.4 East Asia Psoriasis Drugs Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.5 Europe Psoriasis Drugs Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.6 South Asia Psoriasis Drugs Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.7 Southeast Asia Psoriasis Drugs Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.8 Middle East Psoriasis Drugs Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.9 Africa Psoriasis Drugs Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.10 Oceania Psoriasis Drugs Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.11 South America Psoriasis Drugs Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.3 Global Psoriasis Drugs Consumption Volume, Revenue and Price Forecast by Type (2023-2028)
15.3.1 Global Psoriasis Drugs Consumption Forecast by Type (2023-2028)
15.3.2 Global Psoriasis Drugs Revenue Forecast by Type (2023-2028)
15.3.3 Global Psoriasis Drugs Price Forecast by Type (2023-2028)
15.4 Global Psoriasis Drugs Consumption Volume Forecast by Application (2023-2028)
15.5 Psoriasis Drugs Market Forecast Under COVID-19
Chapter 16 Conclusions
Research Methodology
